Follow-up of Pulmonary Radiotoxicity for Bronchopulmonary Cancer.
NCT03931356 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 39
Last updated 2023-02-28
Summary
assess the consequences of low doses of radiation delivered by the volumetric radiotherapy, on the respiratory capacity of patients treated for bronchopulmonary carcinoma, by a follow up of functional respiratory exploration.
Conditions
- Cancer, Lung
- Radiotherapy; Complications
Interventions
- OTHER
-
Pulmonary function tests
analysis of lung volume and diffusion capacity
Sponsors & Collaborators
-
University Hospital, Brest
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-01-14
- Primary Completion
- 2021-09-24
- Completion
- 2022-10-15
Countries
- France
Study Locations
More Related Trials
-
Palliative Short Course Radiotherapy for Advanced Thoracic Cancer
NCT03465553 ·Status: COMPLETED ·Phase: NA
-
Modulation of Anti-tumor T Cell Responses in Cancer Patients Treated by Concomitant Radiochemotherapy
NCT03117946 ·Status: RECRUITING ·Phase: NA
-
Prospective Study on Factors Predicting Chemo-Radiotherapy Induced Pulmonary and Esophageal Injury
NCT00631839 ·Status: UNKNOWN
-
Ventilation Using Radiographic Examination: Functional Lung Imaging Techniques for the Reduction of Toxicity in Functional Avoidance Radiation Therapy
NCT06159660 ·Status: RECRUITING
-
Radiotherapy Dose Complement in the Treatment of Hypoxic Lesions Patients With Stage III Non-small-cell Lung Cancer
NCT01576796 ·Status: UNKNOWN ·Phase: PHASE2
-
Prevention of Radiation Pneumonitis After Three-dimensional Conformal Radiation Therapy (3D-CRT) in Patients With Non-small-cell Lung Cancer
NCT00349102 ·Status: COMPLETED ·Phase: PHASE3
-
A Trial to Evaluate the Improvement in Lung Cancer Patients Receiving Radiation With or Without Brachytherapy
NCT01351116 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Interest of Personalized Radiotherapy Dose Redistribution in Patients With Stage III NSCLC
NCT02473133 ·Status: COMPLETED ·Phase: PHASE2
-
Radiation Pneumonitis After SBRT for NSCLC
NCT02428049 ·Status: ACTIVE_NOT_RECRUITING
-
Improving the Success Rate for Thoracic Radiotherapy Through Specific Cardiac Substructure Dosimetry: Location Matters. (LOCATION MATTERS)
NCT06361784 ·Status: RECRUITING
-
Prevention of Locally Advanced NSCLC Radiotherapy Pneumonia by Inhaling Beclomethasone Propionate
NCT03886441 ·Status: UNKNOWN ·Phase: PHASE2
-
LungTech: Stereotactic Body Radiotherapy (SBRT) of Inoperable Centrally Located NSCLC
NCT01795521 ·Status: UNKNOWN ·Phase: PHASE2
-
Coagulation System In STereotactic Radiotherapy Of NSCLC
NCT03893461 ·Status: UNKNOWN
-
Role of SPECT in Radiotherapy of Lung Cancer and Toxicity Evaluation
NCT01745484 ·Status: COMPLETED ·Phase: NA
-
Detecting Radiation-Induced Cardiac Toxicity After Non-Small Cell Lung Cancer Radiotherapy
NCT03416972 ·Status: UNKNOWN
-
Impact of a Process Optimizing the Decision to Continue or Stop Cancer Treatments in Patients With Advanced Non-small Cell Lung Cancer.
NCT04823377 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Stereotactic Radiotherapy With Different Fractionation Modes for the Early Lung Cancer
NCT05802641 ·Status: UNKNOWN
-
Cardiopulmonary Toxicity of Thoracic Radiotherapy
NCT03978377 ·Status: RECRUITING
-
Study Comparing Two Different Schedules of Radiation for Early-stage Lung Cancer
NCT03706027 ·Status: RECRUITING ·Phase: NA
-
19F Thoracic Radiotherapy for Lung Cancer
NCT03315065 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Predictors of Radiation Pneumonitis in Locally Advanced Lung Cancer Treated With Chemoradiation
NCT01580579 ·Status: COMPLETED
-
Risk Factors of Radiation Pneumonitis
NCT00155909 ·Status: UNKNOWN
-
Positron Emission Tomography and Computed Tomography in Planning Treatment for Patients Undergoing 3-Dimensional Conformal Radiation Therapy for Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery. ICORG 06-35
NCT00958321 ·Status: TERMINATED ·Phase: PHASE2
-
Stereotactic Volumetric Radiotherapy in Prostate Cancer
NCT02423889 ·Status: COMPLETED ·Phase: PHASE2
-
Accelerated Hypofractionated Radiotherapy in the Treatment of Malignant Pleural Mesothelioma
NCT03269227 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA